1 / 1

Makani H et al. BMJ 2013;346:f360 doi : 10.1136/bmj.f360

Comparison of dual blockade of the renin-angiotensin system (RAS) with monotherapy for all cause mortality. Events Total. Risk ratio M-H Random (95% CI). Favours dual RAS Blockade. Favours ACEi ARB, or DRI. 0.05. 1. 20.

eljah
Download Presentation

Makani H et al. BMJ 2013;346:f360 doi : 10.1136/bmj.f360

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Comparison of dual blockade of the renin-angiotensin system (RAS) with monotherapy for all cause mortality Events Total Risk ratio M-H Random (95% CI) Favoursdual RAS Blockade FavoursACEi ARB, or DRI 0.05 1 20 Makani H et al. BMJ 2013;346:f360 doi: 10.1136/bmj.f360

More Related